Advertisement
Singapore markets close in 3 hours 38 minutes
  • Straits Times Index

    3,315.40
    +7.50 (+0.23%)
     
  • Nikkei

    39,097.22
    +480.12 (+1.24%)
     
  • Hang Seng

    18,917.69
    -277.91 (-1.45%)
     
  • FTSE 100

    8,370.33
    -46.12 (-0.55%)
     
  • Bitcoin USD

    69,391.33
    -337.45 (-0.48%)
     
  • CMC Crypto 200

    1,513.38
    -13.03 (-0.85%)
     
  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     
  • Dow

    39,671.04
    -201.95 (-0.51%)
     
  • Nasdaq

    16,801.54
    -31.08 (-0.18%)
     
  • Gold

    2,374.00
    -18.90 (-0.79%)
     
  • Crude Oil

    77.05
    -0.52 (-0.67%)
     
  • 10-Yr Bond

    4.4340
    +0.0200 (+0.45%)
     
  • FTSE Bursa Malaysia

    1,628.31
    +6.22 (+0.38%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,634.50
    +27.28 (+0.41%)
     

23andMe Bringing Genetic Edge to Pharmaceuticals

March 12 -- Jay Lichter, managing director at Avalon Ventures, and Bloomberg’s Caroline Chen discuss the move by 23andMe into drugmaking and discovery and the role might play in the future of the pharmaceutical industry. They speak on “Bloomberg West.”